© 2022 MJH Life Sciences and OncLive - Clinical Oncology News, Cancer Expert Insights. All rights reserved.
2 Clarke DriveSuite 100Cranbury, NJ 08512
© 2022 MJH Life Sciences™ and OncLive - Clinical Oncology News, Cancer Expert Insights. All rights reserved.
September 09, 2016
Matthew H. Kulke, MD, MMSc, discusses the clues obtained from genome sequencing studies in neuroendocrine tumors and the pressing need for further research.
September 08, 2016
Genome sequencing studies are providing clues for therapeutic avenues of inquiry for the most common types of neuroendocrine tumors but are raising as many questions as they answer.
May 16, 2016
Value-based care is becoming a
new catch phrase in American
medicine, especially in the
May 07, 2016
Researchers of Sanford Burnham Prebys Medical Discovery Institute indicates that p62 may represent a link connecting obesity, inflammation, and progression of certain cancers.
May 06, 2016
After a decade of advances in the diagnosis
and treatment of patients with adenocarcinoma
non-small cell lung cancer,
the prospect for further progress remains bright.
May 03, 2016
If germline testing for a cancer-associated purpose reveals the risk of an unrelated
illness like Alzheimer disease, should patients routinely be toldâ€”even if thereâ€™s nothing
that can be done about that â€œincidentalâ€ finding?